☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Turning Point Therapeutics
Zai Lab Signs an Exclusive License Agreement with Turning Point Therapeutics for Repotrectinib in Greater China
July 8, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.